InvestorsHub Logo
Followers 401
Posts 17624
Boards Moderated 0
Alias Born 07/14/2003

Re: None

Wednesday, 05/10/2023 8:30:05 PM

Wednesday, May 10, 2023 8:30:05 PM

Post# of 3258
CRSP- CRSP - CRISPR Therapeutics Revenues and Earnings Beat Expectations

***Earnings per share (EPS) also surpassed analyst estimates by 59%. Looking ahead, revenue is forecast to grow 58% p.a. on average during the next 3 years, compared to a 18% growth forecast for the Biotechs industry in the US.10 hours ago

CRISPR Therapeutics First Quarter 2023 Earnings

Yahoo
https://ca.finance.yahoo.com › news › crispr-therapeutics...
About featured
======================================================================
https://investorshub.advfn.com/boards/read_msg.aspx?message_id=171882880





Join the InvestorsHub Community

Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.